Shareholding change report: Kaihan (46.96% → 45.85%), Evo Fund, etc.

Filer: Evo Fund Date and Time of Filing: May 26, 2026, 12:03 Document Filed: Amendment Report (Cover Page = Amendment Report No. 4) Date Obligation to Report Arose: May 19, 2026 Reason for Filing Amendment Report: Decrease of 1% or more in the ratio of shareholdings, decrease of 1% or more in the ratio of shareholdings on a standalone basis, and changes in the composition of held shares. Issuer: <3133> Kabushiki Kaisha

Jiji Press5minutes ago

Shareholding change report: Kaiho (47.97% → 46.96%), Evo Fund, etc.

Filer: Evo Fund Date and Time of Filing: May 22, 2026, 14:30 Document Filed: Amendment Report (Cover Page = Amendment Report No. 3) Date Obligation Arose: May 15, 2026 Reason for Filing Amendment Report: Decrease of 1% or more in shareholding ratio, decrease of 1% or more in standalone shareholding ratio, and change in the composition of held shares Issuer: <3133> Kabushiki Kaisha

Jiji PressMay 22 01:33 ET

The market remains firm with dip-buying prevailing, but upward momentum may be limited.

[Emerging Market Stock Strategy] The emerging market is expected to remain firm today. In the U.S. stock market on the 15th, the Dow Jones Industrial Average fell significantly by 537.29 points (-1.07%) to close at 49,526.17, extending its decline. Factors weighing on stock prices included disappointment over the U.S.-China summit, rising crude oil prices amid concerns over prolonged conflicts, and expectations of higher interest rates going forward. However, the emerging market is likely to see buying pressure dominate today. Despite major indices falling in the U.S. stock market last week, the Tokyo Stock Exchange Growth Market Index has been on an upward trend since May 11 until the end of last week.

Fisco JapanMay 17 19:20 ET

AViC, MicroAd, and others

GMonster established a subsidiary. Wilsmart entered into a capital and business alliance with Izumiyō Kōgyō, which handles the comprehensive planning, development, construction, and management of amusement parks, various entertainment venues, and parks, through a third-party allotment of new shares (699,600 shares). The research and license agreement between PRISM Bio and Boehringer Ingelheim International GmbH has ended due to the expiration of the contract period. HMCOM is undertaking the next-generation AI implementation project.

Fisco JapanMay 17 18:30 ET

kaihan: Supplementary Financial Results Presentation for the Fiscal Year Ending March 2026

JPXMay 15 04:00 ET · Announcements

kaihan: Notice Regarding the Differences Between the Full-Year Consolidated Earnings Forecast and Actual Results, as well as the Differences Between Individual Segment Results and the Previous Year's Actual Figures

JPXMay 15 04:00 ET · Announcements